Allan Frank Fischer Petersen

Director/Board Member at Biogen (Denmark) A/S

Health Technology

Profile

Allan Frank Fischer Petersen is currently a Director at Biogen (Denmark).
A since 2012.
He previously worked as the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS.

Allan Frank Fischer Petersen active positions

Companies	Position	Start
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Director/Board Member	2012-04-09

All active positions of Allan Frank Fischer Petersen

Former positions of Allan Frank Fischer Petersen

Companies	Position	End
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Chief Executive Officer	-

See the detail of Allan Frank Fischer Petersen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Allan Frank Fischer Petersen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Health Technology
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Health Technology